For hospitals and clinical teams

A shared evidence workflow—introduced with guardrails.

Evaluate how source-visible synthesis can support clinicians across departments without turning an AI response into institutional policy.

Available today

A practical foundation for a limited clinical pilot.

The starting point is the existing Lymph workflow: verified access, organizations, durable evidence work, and inspectable sources.

Verified access

Support practitioner verification and organization-based access for participating clinical teams.

Shared workspaces

Organize clinicians and evidence work within institutional workspaces.

Traceable work

Retain durable conversations and operation records with source-visible responses.

Start small

Define the question before scaling the platform.

01

Choose

Select a department, cohort, and evidence-heavy use case.

02

Guard

Agree deidentification, source, verification, and escalation boundaries.

03

Observe

Review real usage, safety feedback, evidence gaps, and workflow fit.

04

Decide

Expand only after clinical and governance teams review the pilot.

Now

Standalone evidence workspace

Use the current web application with defined participants and deidentified scenarios.

Scoped separately

Institution-specific requirements

SSO, HIS/EHR integration, local protocols, deployment topology, and formal compliance requirements require separate validation and agreement.

Questions from clinical and governance teams

Clear boundaries before deployment.

No. Lymph supports evidence examination. The treating clinician and institution retain responsibility for interpretation and decisions.

For clinical and governance teams

Bring one department and one real workflow.

Use a 30-minute discussion to define whether a structured pilot is appropriate.